Single dose SelfJect corticotropin injection approved by FDA Dr. Kamal Kant Kohli11 Aug 2024 8:45 PM ISTThe US Food and Drug Administration (FDA) has granted approval for supplemental New Drug Application (sNDA) for 'Acthar Gel Single-Dose Pre-filled...
FDA Approves First Nasal Spray for emergency Treatment of serious allergies including Anaphylaxis Dr. Kamal Kant Kohli11 Aug 2024 8:15 PM ISTThe U S Food and Drug Administration has approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I),...
FDA approves Benralizumab as Add-On Maintenance Therapy for kids aged 6 to 11 with severe asthma Dr. Kamal Kant Kohli15 April 2024 6:45 AM ISTAstraZeneca's FASENRA® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients with...
FDA okays pemivibart to prevent COVID-19 in immunocompromised patients Dr. Kamal Kant Kohli26 March 2024 8:30 AM ISTFood and Drug Administration (FDA) has granted emergency use authorization (EUA) for monoclonal antibody pemivibart to prevent COVID-19 in...
First Chikungunya Vaccine gets FDA nod Dr. Kamal Kant Kohli10 Nov 2023 5:07 PM ISTUSA: Ixchiq, the first chikungunya vaccine, has received approval from the U.S. Food and Drug Administration for individuals aged 18 years and above...
FDA Clears First COVID 19 Home Antigen Test Dr. Kamal Kant Kohli10 Nov 2023 9:45 AM ISTThe U.S. Food and Drug Administration has cleared the first over-the-counter (OTC) antigen test for COVID 19 for marketing.ACON Laboratories...
FDA approves phentolamine ophthalmic for reversing pharmacologically-induced mydriasis Dr. Kamal Kant Kohli29 Sept 2023 11:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved RYZUMVI (phentolamine ophthalmic solution) 0.75% for reversing pharmacologically-induced...
FDA approves OTC naloxone nasal spray product for opioid overdose Dr. Kamal Kant Kohli31 July 2023 11:45 AM ISTUSA: RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), has received approval from the U.S. Food and Drug...
First: FDA approves low dose Colchicine for reduction of CV events in high risk patients Medha Baranwal22 Jun 2023 11:00 AM ISTUSA: Colchicine 0.5 mg (Lodoco) has received US FDA (Food and Drug Administration) approval as the first anti-inflammatory indicated for reducing...
FDA approves Omidenepag isopropyl eye drops for reduction of elevated IOP Dr. Kamal Kant Kohli27 Sept 2022 7:30 PM ISTUSA: Glaucoma causes damage to the optic nerve resulting in visual field loss, and remains a leading cause of irreversible blindness worldwide. Since...
FDA approves Immune globulin for pediatric primary humoral immunodeficiency patients Hina Zahid8 Dec 2021 9:00 AM ISTPARAMUS, N.J. - The U.S. Food & Drug Administration (FDA) has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution]...
Viloxazine- recently FDA approved "New drug in the town" Dr. Shivi Kataria18 Aug 2021 9:00 AM ISTOriginally marketed as a bicyclic antidepressant, and FDA designated as an orphan drug for narcolepsy/cataplexy, viloxazine was recently approved...
